A novel drug for the most common cause of dwarfism accelerated children’s growth in a small but closely watched clinical trial, the company BridgeBio said Monday, advancing the latest treatment in ...

Treatment of female mice with an α1-adrenergic antagonist during pregnancy results in dwarfism and insulin resistance in male offspring, according to new findings published in Molecular Metabolism.

With gene therapy, a cure for growth-hormone resistant dwarfism may be on the horizon. National University of Singapore, Yong Loo Lin School of Medicine Researchers from the NUS Yong Loo Lin School of ...

The Food and Drug Administration approved the first treatment for the most common cause of dwarfism Friday, a drug that has proved to increase children’s height but has been polarizing among adults ...

The Food and Drug Administration (FDA) announced Friday that it had approved a drug for children with achondroplasia, the most common form of dwarfism. The drug, Voxzogo, is an injection to improve ...

Oct 20 (Reuters) - The U.S. health regulator on Friday approved the expanded use of BioMarin Pharmaceutical's (BMRN.O), opens new tab once-daily injection to treat children under the age of 5 with the ...

In a retrospective study believed to be one of the largest of its kind, researchers say they have successfully charted the health risks, growth patterns, and medical and surgical outcomes of 1,374 ...

Fifty years ago this week, Apollo 12 landed on the surface of the moon. But it seems this moon mission is overshadowed by the more famous Apollo 11 and Apollo 13 landings. NPR's Geoff Brumfiel reports ...